DSpace DSpace UPC
 Català   Castellano   English  

E-prints UPC >
Altres >
Enviament des de DRAC >

Empreu aquest identificador per citar o enllaçar aquest ítem: http://hdl.handle.net/2117/14797

Ítem no disponible en accés obert per política de l'editorial

Arxiu Descripció MidaFormat
Effects%20of%20duloxetine%20treatment%20on%20brain%20response%20to%20painful%20stimulation%20in%20major%20depressive%20disorder.pdfEffects of duloxetine treatment on brain response to painful stimulation in major depressive disorder607,8 kBAdobe PDF Accés restringit

Citació: López-Solà, M. [et al.]. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder. "Neuropsychopharmacology", 28 Juliol 2010, vol. 35, núm. 11, p. 2305-2317.
Títol: Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder
Autor: Cardoner, Narcís; Vallejo, Julio; Menchón, José M.; López-Solà, Marina; Pujol, Jesus; Hernández-Ribas, Rosa; Harrison, Ben J.; Contreras-Rodríguez, Oren; Soriano-Mas, Carles; Deus, Joan; Ortiz Valencia, Héctor Veure Producció científica UPC
Data: 28-jul-2010
Tipus de document: Article
Resum: Major depressive disorder (MDD) is characterized by a constellation of affective, cognitive, and somatic symptoms associated with functional abnormalities in relevant brain systems. Painful stimuli are primarily stressful and can trigger consistent responses in brain regions highly overlapping with the regions altered in MDD patients. Duloxetine has proven to be effective in treating both core emotional symptoms and somatic complaints in depression. This study aimed to assess the effects of duloxetine treatment on brain response to painful stimulation in MDD patients. A total of 13 patients and a reference group of 20 healthy subjects were assessed on three occasions (baseline, treatment week 1, and week 8) with functional magnetic resonance imaging (fMRI) during local application of painful heat stimulation. Treatment with duloxetine was associated with a significant reduction in brain responses to painful stimulation in MDD patients in regions generally showing abnormally enhanced activation at baseline. Clinical improvement was associated with pain-related activation reductions in the pregenual anterior cingulate cortex, right prefrontal cortex, and pons. Pontine changes were specifically related to clinical remission. Increased baseline activations in the right prefrontal cortex and reduced deactivations in the subgenual anterior cingulate cortex predicted treatment responders at week 8. This is the first fMRI study addressed to assess the effect of duloxetine in MDD. As a novel approach, the application of painful stimulation as a basic neural stressor proved to be effective in mapping brain response changes associated with antidepressant treatment and brain correlates of symptom improvement in regions of special relevance to MDD pathophysiology.
ISSN: 0893-133X
URI: http://hdl.handle.net/2117/14797
Versió de l'editor: http://www.nature.com/npp/journal/v35/n11/full/npp2010108a.html
Apareix a les col·leccions:Altres. Enviament des de DRAC
GIIP - Grup de Recerca en Enginyeria de Projectes: Disseny, Sostenibilitat i Comunicació. Articles de revista
Departament de Projectes d'Enginyeria. Articles de revista
Comparteix:


Stats Mostra les estadístiques d'aquest ítem

SFX Query

Aquest ítem (excepte textos i imatges no creats per l'autor) està subjecte a una llicència de Creative Commons Llicència Creative Commons
Creative Commons

 

Valid XHTML 1.0! Programari DSpace Copyright © 2002-2004 MIT and Hewlett-Packard Comentaris
Universitat Politècnica de Catalunya. Servei de Biblioteques, Publicacions i Arxius